На этой странице перечислены больницы направления «Кардиология» (включая Balloon Pulmonary Valvuloplasty) в Ченнаи, Индия, включая Apollo Hospitals, Greams Road, Gleneagles Global Hospital, Dr. Rela Institute and Medical Centre, SIMS Hospital и другие.
Спросите нас о «Balloon Pulmonary Valvuloplasty» в Ченнаи, Индия
Оставьте свои данные — наша команда координации свяжется с вами и расскажет о следующих шагах.
Сравните 8 аккредитованных больниц (Кардиология) в Ченнаи, Индия
Рекомендуем🇮🇳 Apollo Hospitals, Greams Road
Больница занимает 1-е место в этом списке по указанному рейтингу (4.7/5, 125 отзывов).
🇮🇳 Gleneagles Global Hospital
Больница занимает 2-е место в этом списке по указанному рейтингу (4.7/5, 112 отзывов).
🇮🇳 Dr. Rela Institute and Medical Centre
Больница занимает 3-е место в этом списке по указанному рейтингу (4.7/5, 108 отзывов).
🇮🇳 SIMS Hospital
Больница занимает 4-е место в этом списке по указанному рейтингу (4.6/5, 20 отзывов).
🇮🇳 Sankara Nethralaya
Больница занимает 5-е место в этом списке по указанному рейтингу (4.4/5, 220 отзывов).
🇮🇳 Apollo First Med Hospitals, Kilpauk
Больница занимает 6-е место в этом списке по указанному рейтингу (4.4/5, 76 отзывов).
🇮🇳 MIOT International
Больница занимает 7-е место в этом списке по указанному рейтингу (4.4/5, 200 отзывов).
🇮🇳 MGM Healthcare
Больница занимает 8-е место в этом списке по указанному рейтингу (3.7/5, 34 отзывов).
Как мы выбираем эти больницы
Больница появляется на этой странице, если направление «Кардиология» указано среди её специализаций и она находится в Ченнаи, Индия. Сортировка — по указанному рейтингу (по убыванию), без редакционного рейтинга «лучших».
Как выбрать лучшую больницу для «balloon pulmonary valvuloplasty» в Ченнаи, Индия?
Выбор подходящей больницы для «balloon pulmonary valvuloplasty» — важное решение в вашем пути лечения. Вот на что стоит обратить внимание:
Международная аккредитация
Ищите больницу с международной аккредитацией, например JCI или NABH — см. отметки аккредитации у каждой больницы ниже.
Специализация
Убедитесь, что в больнице есть отделение, специализирующееся на «Кардиология», а не только общая помощь.
Мощность и опыт
Количество коек и год основания, указанные ниже, отражают масштаб и операционный опыт больницы.
Прозрачность стоимости
Запросите детализированную смету перед поездкой — используйте наш калькулятор стоимости для первичной оценки.
Что нужно знать о процедуре «Balloon Pulmonary Valvuloplasty»
Balloon Pulmonary Valvuloplasty (BPV) is a minimally invasive, catheter-based procedure that uses a high-pressure balloon to widen a narrowed pulmonary valve, restoring normal blood flow from the right ventricle to the pulmonary artery without open-heart surgery. The procedure carries a clinical success rate exceeding 90% in appropriately selected patients and is considered the definitive standard of care for moderate-to-severe pulmonary valve stenosis by leading cardiology societies worldwide. GAF Healthcare connects international patients with JCI- and NABH-accredited cardiac centers in India and JCI- and DHA-accredited hospitals in Dubai and Abu Dhabi, offering expert interventional cardiology, transparent pricing, and end-to-end medical travel coordination. Hospital Stay: 2–4 days • Total Stay in Country (Fit-to-Fly): 1–2 weeks • Success Rate: 90–95%
Clinical Overview
Pulmonary valve stenosis (PVS) is a structural cardiac defect characterized by the pathological narrowing of the pulmonary valve orifice, which impedes the ejection of deoxygenated blood from the right ventricle (RV) into the pulmonary artery. In a healthy heart, the tricuspid pulmonary valve opens freely during systole; in PVS, fused or dysplastic leaflets create a fixed obstruction that forces the RV to generate abnormally elevated pressures to maintain adequate cardiac output. Over time, sustained pressure overload leads to progressive right ventricular hypertrophy (RVH), diastolic dysfunction, tricuspid regurgitation, and—in severe cases—right heart failure, paradoxical emboli through a patent foramen ovale, and systemic desaturation. The condition is most commonly congenital but can also arise as a sequela of rheumatic heart disease or carcinoid syndrome. The hemodynamic severity of PVS is graded by the peak instantaneous Doppler gradient across the valve on transthoracic echocardiography (TTE): mild stenosis is defined as a gradient below 36 mmHg, moderate stenosis as 36–64 mmHg, and severe stenosis as a gradient exceeding 64 mmHg. Cardiac magnetic resonance imaging (CMR) and right heart catheterization are used to quantify RV volumes, ejection fraction, and the precise transvalvular gradient when non-invasive data are inconclusive. Current guidelines from the American College of Cardiology (ACC/AHA) and the European Society of Cardiology (ESC) recommend intervention whenever the peak-to-peak catheterization gradient exceeds 40 mmHg, or at lower gradients in the setting of symptomatic disease, RV dysfunction, or planned cardiac surgery for a concurrent defect. Balloon Pulmonary Valvuloplasty, first described by Kan et al. in 1982, has firmly supplanted surgical valvotomy as the primary interventional strategy for typical dome-shaped congenital pulmonary stenosis. Using fluoroscopic and echocardiographic guidance, a specially designed valvuloplasty balloon catheter—introduced percutaneously via the femoral vein—is positioned across the stenotic valve and inflated to 3–5 atmospheres of pressure, fracturing the fused commissures and achieving immediate, durable reduction in the transvalvular gradient. High-volume cardiac catheterization laboratories in India and the UAE perform this procedure using state-of-the-art biplane cath labs, intracardiac echocardiography (ICE), and real-time hemodynamic monitoring, delivering outcomes comparable to the world's premier cardiac institutions.
Who is a Candidate?
• ELIGIBLE PATIENTS: • Congenital pulmonary valve stenosis with a peak Doppler gradient ≥ 40 mmHg on TTE (ACC/AHA Class I indication) • Symptomatic patients (exertional dyspnea, syncope, chest pain, reduced exercise tolerance) at any gradient above 30 mmHg • Asymptomatic patients with a peak gradient ≥ 50 mmHg or evidence of progressive right ventricular hypertrophy on CMR or ECG • Pediatric patients (including neonates with critical pulmonary stenosis) and adults up to any age with suitable valve morphology • Patients with concurrent patent foramen ovale (PFO) or atrial septal defect (ASD) where elevated RV pressure is driving right-to-left shunting • Post-surgical residual pulmonary stenosis with hemodynamically significant re-stenosis • REQUIRED DIAGNOSTIC WORK-UP: • Transthoracic Echocardiography (TTE) with continuous-wave Doppler: primary modality for gradient quantification, RV size, and systolic function • Transesophageal Echocardiography (TEE) or Intracardiac Echocardiography (ICE): detailed valve morphology and guidance during intervention • Cardiac MRI (CMR): RV volumetry, ejection fraction, and fibrosis assessment in complex cases • Right Heart Catheterization: definitive measurement of peak-to-peak and mean transvalvular gradients, RV and pulmonary artery pressures • 12-Lead ECG: assessment for RV strain pattern (right axis deviation, R-wave dominance in V1) • Chest X-Ray: post-stenotic pulmonary artery dilatation, cardiac silhouette • Complete Blood Count (CBC), Renal Function Tests, Coagulation Profile (PT/INR, aPTT): pre-procedural safety screening • Oxygen saturation at rest and on exercise (6-minute walk test): functional capacity baseline • CONTRAINDICATIONS: • Severe pulmonary valve dysplasia with markedly thickened, irregular, non-domed leaflets (surgical valvotomy or Ross procedure preferred) • Isolated infundibular (subvalvular) stenosis without valvular component • Supravalvular pulmonary artery stenosis (branch PA stenosis requires stenting or surgery) • Active infective endocarditis involving the pulmonary valve • Severe pulmonary regurgitation already present (BPV will worsen regurgitation) • Uncorrectable coagulopathy or active systemic infection • Anatomy precluding femoral venous access (alternative: internal jugular or transhepatic approach in selected cases)
Treatment Options & Approaches
STANDARD BALLOON PULMONARY VALVULOPLASTY (PRIMARY APPROACH): The conventional technique uses a single Inoue-style or dedicated pulmonary valvuloplasty balloon catheter (Tyshak II or Z-Med series). Under biplane fluoroscopic guidance, venous access is secured via the femoral vein using a 7–9 French sheath. A multipurpose or right Judkins catheter is advanced through the right atrium, across the tricuspid valve, through the RV, and positioned across the pulmonic valve into the distal pulmonary artery. A stiff exchange-length guidewire (e.g., Amplatz Super Stiff) is parked in the left pulmonary artery. The valvuloplasty balloon—sized to a balloon-to-annulus ratio (BAR) of 1.2–1.4:1, the critical determinant of efficacy and complication risk—is advanced over the wire, centered across the stenotic valve, and inflated rapidly to obliterate the fluoroscopic waist created by the obstructing leaflets. The balloon is then rapidly deflated and withdrawn. Immediate post-dilation hemodynamics and echocardiography confirm the residual gradient. A successful result is defined as a post-procedural peak gradient below 25–30 mmHg or a reduction of ≥ 50% from baseline. DOUBLE-BALLOON TECHNIQUE: For large pulmonary annuli (typically > 20–22 mm in adults and older adolescents), the single-balloon approach may be limited by available balloon diameters. The double-balloon technique employs two balloons advanced simultaneously via bilateral femoral venous access, with their combined effective diameter calculated using the Yeager formula to achieve the optimal BAR. This approach allows treatment of annuli up to 30 mm and is associated with superior gradient reduction and lower residual stenosis compared to single-balloon dilation in large adults. CUTTING BALLOON AND HIGH-PRESSURE BALLOON FOR RESTENOSIS: In patients presenting with restenosis following prior BPV or surgical valvotomy—where leaflet fibrosis and calcification reduce compliance—standard low-pressure balloons may be insufficient. Cutting balloons (Flextome, Boston Scientific) carry 3–4 atherotomes that score the resistant leaflet tissue, enabling effective commissurotomy at lower inflation pressures with reduced risk of annular trauma. High-pressure non-compliant balloons (up to 18–22 atm) are an alternative in calcified valves. PULMONARY VALVE STENTING (TRANSCATHETER PULMONARY VALVE IMPLANTATION / TPVI): In patients with dysplastic pulmonary valves unsuitable for BPV alone, severe post-BPV pulmonary regurgitation causing hemodynamic compromise, or conduit-related RVOT obstruction (e.g., following tetralogy of Fallot repair), Transcatheter Pulmonary Valve Implantation (TPVI) using the Melody valve (Medtronic) or the SAPIEN XT/3 valve (Edwards Lifesciences) is the advanced catheter-based alternative to surgical pulmonary valve replacement. This procedure is performed in specialized hybrid cath-lab/OR suites available at premier cardiac centers in India and the UAE. INTRACARDIAC ECHOCARDIOGRAPHY (ICE) GUIDANCE: Lead centers in Mumbai, Chennai, Delhi, Dubai, and Abu Dhabi integrate real-time ICE (AcuNav catheter, Siemens ACUSON X300) into the BPV procedure to permit precise balloon sizing, confirm wire position, monitor for immediate pericardial effusion, and assess post-dilation valve competence—reducing reliance on general anesthesia and TEE. SEDATION PROTOCOLS: Adults and cooperative older children typically undergo BPV under conscious sedation (midazolam + fentanyl) or light procedural anesthesia with propofol infusion, avoiding the risks of general anesthesia. Neonates, infants, and young children require general anesthesia with full hemodynamic monitoring.
Восстановление
PHASE 1 — PRE-ARRIVAL & REMOTE CONSULTATION (2–4 weeks before travel): • Patient submits medical records (echocardiography reports, CMR, prior cath data, ECG, blood work) to GAF Healthcare's clinical team via the secure online portal. • A GAF-affiliated senior interventional cardiologist reviews the case and issues a formal treatment opinion within 48–72 hours, including procedure recommendation, balloon sizing estimation, and risk stratification. • GAF coordinates e-Medical Visa (India) or UAE entry visa processing; travel and accommodation booking is initiated for patient and one attendant. PHASE 2 — ARRIVAL & PRE-PROCEDURAL ASSESSMENT (Day 1–2): • Airport pickup by GAF's dedicated medical concierge team; transfer to partner hospital or pre-arranged serviced apartment. • Day 1: Hospital admission, clinical assessment by the interventional cardiology team, repeat TTE to confirm current gradients and RV function, baseline ECG, chest X-ray. • Day 2 (if not done Day 1): Right heart catheterization (diagnostic) under local anesthesia to confirm hemodynamic severity; finalize balloon sizing using annulus measurement from TTE/CMR; anesthesia pre-assessment; consent process with translator present if needed. • Pre-procedural medications: antiplatelet therapy (aspirin 75–100 mg if not already prescribed), prophylactic low-molecular-weight heparin in selected high-risk patients. PHASE 3 — THE PROCEDURE (Day 2 or Day 3; duration: 60–120 minutes): • Patient transferred to biplane cardiac catheterization laboratory; ECG, pulse oximetry, and invasive arterial pressure monitoring established. • Conscious sedation or general anesthesia administered per pre-agreed protocol. • Right femoral vein accessed under ultrasound guidance; 8 French sheath inserted. • Diagnostic right heart catheterization performed: RV and PA pressures recorded, oxygen saturations measured, Fick cardiac output calculated. • Stiff guidewire advanced into the distal left pulmonary artery. • Valvuloplasty balloon (sized to BAR 1.2–1.4:1) advanced across the stenotic pulmonary valve under fluoroscopic and ICE guidance. • Rapid inflation–deflation sequence (3–5 seconds per inflation) performed 2–3 times until the fluoroscopic waist is abolished. • Immediate post-dilation hemodynamics recorded; residual gradient < 25 mmHg confirms technical success. • Sheath removed; femoral access site compressed manually or with closure device; sterile dressing applied. PHASE 4 — IMMEDIATE POST-PROCEDURAL RECOVERY (Day 3–4): • Patient monitored in cardiac recovery unit for 4–6 hours: ECG telemetry, repeat TTE at 24 hours to document gradient reduction and rule out pericardial effusion. • Bed rest for 6 hours post-procedure; ambulation commenced the same evening. • Oral hydration resumed within 2 hours; regular diet by Day 3 morning. • Discharge criteria: stable hemodynamics, residual gradient ≤ 30 mmHg on TTE, no arrhythmia on telemetry, access site intact. • Most patients are discharged on Day 3 or Day 4 post-admission. PHASE 5 — IN-COUNTRY RECOVERY BEFORE DEPARTURE (Days 4–10): • Patient stays in partner serviced apartment with GAF concierge support; daily telephone check-in with the cardiac team. • Mild activity (walking) encouraged from Day 3; strenuous activity (lifting > 5 kg, vigorous exercise) restricted for 2 weeks. • No driving for 48 hours post-procedure; no heavy lifting for 1 week. • Discharge medications typically include aspirin 75 mg for 1–3 months and, in patients with residual RV dysfunction, guideline-directed doses of loop diuretics (furosemide) or beta-blockers as clinically indicated. PHASE 6 — FIT-TO-FLY ASSESSMENT (Day 7–10): • Outpatient follow-up TTE and clinical review; if the residual gradient is stable and there are no complications, the cardiologist issues a fit-to-fly certificate. • For most uncomplicated cases, international air travel is cleared at 7–10 days post-procedure. • GAF Healthcare provides a complete digital discharge summary, imaging CDs/USB, and procedure report for the patient's home cardiologist. PHASE 7 — LONG-TERM FOLLOW-UP: • TTE recommended at 1 month, 6 months, and annually thereafter. • Re-stenosis rate is approximately 5–10% at 5 years in pediatric patients with rapid somatic growth and approximately 3–5% in adults. • GAF Healthcare facilitates remote follow-up teleconsultation with the treating cardiologist at 1 and 6 months post-discharge.
Возможные риски
Balloon Pulmonary Valvuloplasty is considered a low-to-moderate risk procedure with a procedural mortality rate below 0.5% in experienced centers for elective cases. However, patients and families must be counseled on the following clinically relevant risks and considerations: Pulmonary regurgitation (PR) is the most common post-procedural sequela, occurring in up to 75–85% of patients in mild-to-moderate degree following successful BPV. In the vast majority, mild-to-moderate PR is well tolerated for decades; however, severe PR—more common after over-dilation (BAR > 1.4:1) or in dysplastic valves—can cause progressive right ventricular volume overload and may eventually necessitate pulmonary valve replacement (surgical or transcatheter). Long-term echocardiographic surveillance is therefore mandatory. Residual pulmonary stenosis (post-procedural peak gradient > 36 mmHg) occurs in approximately 10–15% of patients, most commonly in those with dysplastic or heavily calcified valves. These patients may require repeat BPV or surgical intervention. Right ventricular outflow tract (RVOT) spasm can cause transient hypotension and oxygen desaturation immediately following balloon dilation; this is managed with intravenous phenylephrine, volume loading, and, if severe, beta-blocker administration (esmolol or propranolol) to reduce dynamic obstruction. Vascular access site complications—including femoral vein hematoma, arteriovenous fistula, or deep vein thrombosis—occur in 1–3% of cases and are minimized through ultrasound-guided access and meticulous post-procedure compression. Cardiac arrhythmias, including transient complete heart block, right bundle branch block, or supraventricular tachycardia, may occur during catheter manipulation within the right ventricle. These are typically self-limiting but may require temporary pacing or cardioversion in rare instances. Pericardial tamponade due to cardiac perforation is rare (< 0.1%) but requires immediate pericardiocentesis. Neonates with critical pulmonary stenosis undergoing emergency BPV carry substantially higher procedural risk (mortality up to 3–5%) and require a specialized neonatal cardiac intensive care unit, available at GAF Healthcare's partner quaternary cardiac centers.
Почему GAF Healthcare
GAF Healthcare provides fully integrated, non-medical travel and logistical support to ensure that international patients can focus entirely on their recovery. INDIA: GAF Healthcare assists international patients in obtaining the e-Medical Visa (eMV) for India, which is available to citizens of 156+ countries, is processed entirely online within 3–5 business days, and permits stays of up to 60 days per visit with two entries. We guide patients through the application, document upload (hospital invitation letter, passport, photograph), and fee payment. Upon arrival at the designated international airport (Delhi IGI, Mumbai CSIA, Chennai MAA, Hyderabad HYD, Bengaluru KIA), a dedicated GAF medical concierge representative meets the patient and attendant, assists with immigration if needed, and arranges a private, air-conditioned vehicle transfer directly to the partner hospital or serviced accommodation. UAE (DUBAI / ABU DHABI): Citizens of over 50 countries—including the GCC, EU, UK, USA, Canada, Australia, and many Asian nations—receive a visa-on-arrival or visa-free access to the UAE for 14–90 days depending on nationality. Citizens of other countries can obtain a UAE Medical Treatment Visa (30-day, extendable) through GAF Healthcare's UAE coordination team. Dubai International Airport (DXB) and Abu Dhabi International Airport (AUH) are among the world's most connected aviation hubs, with direct flights available from most major cities in Africa, the Middle East, South Asia, and Europe, making the UAE particularly advantageous for patients from these regions. GAF's UAE team arranges private airport transfers and accommodation in medical-grade serviced apartments within 10–15 minutes of the partner hospital. ACCOMMODATION FOR ATTENDANTS: GAF Healthcare pre-negotiates preferred rates at partner serviced apartments and hospital guesthouses in all destination cities, accommodating the patient's companion (spouse, parent, or caregiver) in comfortable proximity to the treating facility. Apartments with kitchen facilities are prioritized to accommodate dietary preferences. DEDICATED TRANSLATION & CULTURAL SUPPORT: For patients from Arabic-speaking, Russian-speaking, African, and other non-English language communities, GAF Healthcare assigns a certified medical interpreter fluent in the patient's language for all clinical consultations, consent discussions, and discharge briefings. Cultural dietary requirements are communicated to the hospital dietary team in advance. DIGITAL CARE COORDINATION: Every GAF patient is assigned a personal Case Manager who maintains a single WhatsApp/email thread covering appointment scheduling, lab result communication, billing queries, pharmacy prescriptions, and post-discharge follow-up—eliminating the administrative burden on the patient and family throughout their medical journey.
Частые вопросы о процедуре «Balloon Pulmonary Valvuloplasty»
What is the cost of Balloon Pulmonary Valvuloplasty in India versus the UAE?
How long do I need to stay in India or the UAE before I am considered fit to fly home after Balloon Pulmonary Valvuloplasty?
What is the success rate of Balloon Pulmonary Valvuloplasty, and how durable are the results?
Похожие страницы
Как GAF Healthcare помогает выбрать лучшую больницу для «balloon pulmonary valvuloplasty» в Ченнаи, Индия
Найдите лучшие больницы для «balloon pulmonary valvuloplasty» в Ченнаи, Индия
На этой странице представлено 8 больниц в Ченнаи, Индия, чтобы вы могли сравнить аккредитацию и специализации в одном месте.
Поддержка, когда она нужна
Отправьте нам свои медицинские отчёты в WhatsApp или по email — наша медицинская команда изучит их и предложит больницу и план лечения.
Прозрачные, всё включено цены
Мы предоставляем единую детализированную смету, покрывающую расходы больницы и проживание — без скрытых платежей.
Организация визы, поездки и проживания
После выбора больницы мы помогаем оформить визовое приглашение, забронировать проживание рядом с больницей и организовать трансфер.
Хотите узнать примерную стоимость лечения? Используйте наш калькулятор стоимости для персональной оценки.
Частые вопросы о «Balloon Pulmonary Valvuloplasty» в Ченнаи, Индия
Сколько больниц направления «Кардиология» представлено в Ченнаи, Индия?
Как вы выбираете больницы для списка?
Сколько стоит лечение в Ченнаи, Индия?
Следующий шаг
Отправьте нам свои медицинские отчёты — наша команда предложит больницу и план лечения для «Balloon Pulmonary Valvuloplasty» в Ченнаи, Индия.
Свяжитесь с нами, если заметите неточность на этой странице.